Phase 1 multicenter, dose-expansion study of ARX788 as monotherapy in HER2-positive advanced gastric and gastroesophageal junction adenocarcinomaYang Zhang, Rui‐Hua Xu, Ao Shen et al.|Cell Reports Medicine|2022Cited by 51
Nanodelivery of a functional membrane receptor to manipulate cellular phenotypeTommaso Patriarchi, Lin Tian, Ao Shen et al.|Scientific Reports|2018Cited by 16